Vascular Surgery Unit, 472674ASST Fatebenefratelli-Sacco, Milan, Italy.
Laboratory of Research in Vascular Surgery, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Phlebology. 2022 Oct;37(9):686-688. doi: 10.1177/02683555221114537. Epub 2022 Jul 9.
The term "recurrence" in chronic venous disease remains not yet well defined, despite numerous reports describing patterns and causes of the presence of recurrent varicose veins (RVVs). Moreover, saphenous trunk recanalization (STR) has also been documented as one of the major source of RVVs and it is widely used to indicate the "failure" of endovenous ablation. Finally, reappearance of venous symptoms (VSym) should be considered to reach a complete "recurrence" evaluation. RVVs, STR, and VSym rates and mutual co-presence after endovenous treatments are still unclear. The aim of this report is to describe and analyze these three recurrence components after 6 years in patients underwent radiofrequency ablation of the great saphenous vein.
尽管有许多报告描述了复发性静脉曲张（RVV）的模式和原因，但慢性静脉疾病中“复发”一词仍未得到很好的定义。此外，大隐静脉主干再通（STR）也被记录为 RVV 的主要来源之一，并且广泛用于表示静脉内消融治疗的“失败”。最后，静脉症状（VSym）的再次出现也应被视为达到完整“复发”评估的标准。静脉内治疗后 RVV、STR 和 VSym 的发生率以及它们之间的共同存在情况尚不清楚。本报告的目的是描述和分析接受射频消融治疗大隐静脉 6 年后这三种复发成分。
